Tomorrow Health closes funding, boosts board
By HME News Staff
Updated 9:30 AM CDT, Mon April 19, 2021
.jpg)
NEW YORK – Tomorrow Health has closed a $25 million Series A round of funding led by Andreessen Horowitz with participation from Obvious Ventures and BoxGroup. The company has also added Paul Mango, former deputy chief of staff for policy at HHS, and Roy Beveridge, former chief medical officer at Humana, to its advisory board. “We believe the home should be a patient’s primary point of care, and we are focused on providing patients with the right products, guidance and support to make that a reality,” said Vijay Kedar, co-founder and CEO. “We are committed to getting each patient’s individual needs fulfilled in partnership with the highest-quality suppliers and to removing the stress and complexity that have become synonymous with navigating at-home care.” Since launching in April 2020, Tomorrow Health has partnered with more than 125 health plans and hospital systems. The company says it is now focused on hiring additional talent and expanding its infrastructure technology.
Comments